Background

Liposomal bupivacaine is reported to prolong the duration of analgesia when used for abdominal fascial plane blocks compared to plain local anesthetics; however, evidence from randomized trials is mixed. This meta-analysis aims to compare the analgesic effectiveness of liposomal bupivacaine to plain local anesthetics in adults receiving abdominal fascial plane blocks.

Methods

Randomized trials comparing liposomal bupivacaine and plain (nonliposomal) local anesthetics in abdominal fascial plane blocks were sought. The primary outcome was area under the curve rest pain between 24 to 72 h postoperatively. Secondary outcomes included rest pain at individual timepoints (1, 6, 12, 24, 48, and 72 h); analgesic consumption at 0 to 24, 25 to 48, and 49 to 72 h; time to analgesic request; hospital stay duration; and opioid-related side effects. Data were pooled using the Hartung-Knapp-Sidik-Jonkman random effects method.

Results

Sixteen trials encompassing 1,287 patients (liposomal bupivacaine, 667; plain local anesthetics, 620) were included. The liposomal bupivacaine group received liposomal bupivacaine mixed with plain bupivacaine in 10 studies, liposomal bupivacaine alone in 5 studies, and both preparations in 1 three-armed study. No difference was observed between the two groups for area under the curve pain scores, with a standardized mean difference (95% CI) of –0.21 cm.h (–0.43 to 0.01; P = 0.058; I2 = 48%). Results were robust to subgroup analysis based on (1) potential conflict of interest and (2) mixing of plain local anesthetics with liposomal bupivacaine. The two groups were not different for any of the day 2 or day 3 secondary outcomes.

Conclusions

This systematic review and meta-analysis suggests similar analgesic effectiveness between liposomal bupivacaine and plain local anesthetics when used for fascial plane block of the abdominal wall. The authors’ analysis does not support an evidence-based preference for liposomal bupivacaine compared to plain local anesthetics for abdominal fascial plane blocks.

Editor’s Perspective
What We Already Know about This Topic
  • Liposomal bupivacaine has been reported by some to prolong the duration of analgesia when used for abdominal fascial plane blocks compared to that produced by traditional plain local anesthetic agents
What This Article Tells Us That Is New
  • This systematic review and meta-analysis compared the analgesic effectiveness of liposomal bupivacaine to that of plain local anesthetics in adult patients receiving abdominal fascial plane blocks
  • Thirteen randomized trials of 874 patients were included in the analysis of the primary outcome, the mean difference in the area under the curve for pain severity scores at rest between 24 and 72 h postoperatively
  • There was no difference in area under the curve for pain severity scores at rest between 24 and 72 h postoperatively between the liposomal bupivacaine group and the plain local anesthetics group
  • There were also no clinically important differences between the groups in secondary outcomes including rest pain scores and opioid consumption up to 72 h postoperatively and no statistical differences in time to first analgesic request, time to hospital discharge, and incidence of opioid-related side effects